Guoqiang Xu

23PUBLICATIONS
34CO-AUTHORS
Haematological tumoursReaction engineering (excl. nuclear reactions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 06, 2026
Structural insights into the MLH1-FAN1 interaction reveal an uncharacterized binding interface on MLH1.

|Apr 11, 2026
Expedient Chemical Synthesis of Ufmylated Histones Using Chemoenzymatic C-Terminal Hydrazinolysis of Ubiquitin-Fold Modifier 1.

Xin Liu, Cong Chen, Fang Li

|Mar 20, 2026
The sulfonamide anticancer agent indisulam enhances the chemosensitivity of gastric cancer cells by targeting FKBP8.

Yue Li, Chengpiao Lu, Jiaqi Lu

|Aug 28, 2025
DCAF7 recruits USP2 to facilitate hepatocellular carcinoma progression by suppressing clockophagy-induced ferroptosis.

Honglv Jiang, Xiaohui Wang, Zhenhua Zhu

|Jul 02, 2024
Efficient Chemical Synthesis of Multi-Monoubiquitylated and Diubiquitylated Histones by the α-Halogen Ketone-Mediated Strategy.

Shuai Peng, Xin Liu, Chengpiao Lu

|May 14, 2024
The NTE domain of PTENα/β promotes cancer progression by interacting with WDR5 via its SSSRRSS motif.

Xiaolei Huang, Cheng Zhang, Xinci Shang

Pageof 4

Frequent Collaborators

3 joint publications

Yanli Liu

2 joint publications

Jingjing Ma

2 joint publications

Yibo Zuo

2 joint publications

Hui Zheng